Showing results (91-100 of 668) with videos related to
Sort By:
Pageof 67
Advances in Pharmacology (San Diego, Calif.)|July 27, 2025
Cellular senescence and senotherapeutics in cardiovascular diseasesArttatrana PalAdvances in Pharmacology (San Diego, Calif.)|July 27, 2025
Oxygen-ozone adjunct therapy in aging and senescence-related disorders. State of artSalvatore Chirumbolo, Giovanni Ricevuti, Marianno Franzini, et al.Advances in Pharmacology (San Diego, Calif.)|February 26, 2013
Redefining approaches to asthma: developing targeted biologic therapiesJoseph R Arron, Heleen Scheerens, John G MatthewsAdvances in Pharmacology (San Diego, Calif.)|February 26, 2013
Immunopharmacology of lipid A mimeticsWilliam S Bowen, Siva K Gandhapudi, Joseph P Kolb, et al.Advances in Pharmacology (San Diego, Calif.)|October 14, 2014
Functional expression of drug transporters in glial cells: potential role on drug delivery to the CNSTamima Ashraf, Amy Kao, Reina BendayanAdvances in Pharmacology (San Diego, Calif.)|October 14, 2014
Delivery of chemotherapeutics across the blood-brain barrier: challenges and advancesNancy D Doolittle, Leslie L Muldoon, Aliana Y Culp, et al.Advances in Pharmacology (San Diego, Calif.)|October 14, 2014
Pharmacological significance of prostaglandin E2 and D2 transport at the brain barriersMasanori Tachikawa, Ken-ichi Hosoya, Tetsuya TerasakiAdvances in Pharmacology (San Diego, Calif.)|October 14, 2014
Steroids and the blood-brain barrier: therapeutic implicationsKen A Witt, Karin E SandovalAdvances in Pharmacology (San Diego, Calif.)|September 24, 2013
Brain neurons partly expressing dopaminergic phenotype: location, development, functional significance, and regulationMichael V UgrumovAdvances in Pharmacology (San Diego, Calif.)|September 24, 2013
Selective ablation of dopamine β-hydroxylase neurons in the brain by immunotoxin-mediated neuronal targeting: new insights into brain catecholaminergic circuitry and catecholamine-related diseasesKeiichi Itoi, Shinji Ohara, Kazuto KobayashiPageof 67